SK17152002A3 - Hydrojodid 5-[4-[2-(N-metyl-N-(2-pyridyl)amíno)etoxy]- benzyl]tiazolidín-2,4-diónu ako liečivo - Google Patents

Hydrojodid 5-[4-[2-(N-metyl-N-(2-pyridyl)amíno)etoxy]- benzyl]tiazolidín-2,4-diónu ako liečivo Download PDF

Info

Publication number
SK17152002A3
SK17152002A3 SK1715-2002A SK17152002A SK17152002A3 SK 17152002 A3 SK17152002 A3 SK 17152002A3 SK 17152002 A SK17152002 A SK 17152002A SK 17152002 A3 SK17152002 A3 SK 17152002A3
Authority
SK
Slovakia
Prior art keywords
hydroiodide
methyl
pyridyl
ethoxy
benzyl
Prior art date
Application number
SK1715-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael John Millan
Original Assignee
Smithkline Beecham P. L. C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P. L. C. filed Critical Smithkline Beecham P. L. C.
Publication of SK17152002A3 publication Critical patent/SK17152002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1715-2002A 2000-06-08 2001-06-08 Hydrojodid 5-[4-[2-(N-metyl-N-(2-pyridyl)amíno)etoxy]- benzyl]tiazolidín-2,4-diónu ako liečivo SK17152002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014005.3A GB0014005D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002545 WO2001094343A1 (en) 2000-06-08 2001-06-08 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical

Publications (1)

Publication Number Publication Date
SK17152002A3 true SK17152002A3 (sk) 2003-05-02

Family

ID=9893256

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1715-2002A SK17152002A3 (sk) 2000-06-08 2001-06-08 Hydrojodid 5-[4-[2-(N-metyl-N-(2-pyridyl)amíno)etoxy]- benzyl]tiazolidín-2,4-diónu ako liečivo

Country Status (26)

Country Link
US (1) US20040024027A1 (ko)
EP (1) EP1292595A1 (ko)
JP (1) JP2003535861A (ko)
KR (1) KR20030007919A (ko)
CN (1) CN1443185A (ko)
AP (1) AP2002002684A0 (ko)
AU (2) AU2001262550B2 (ko)
BG (1) BG107356A (ko)
BR (1) BR0111508A (ko)
CA (1) CA2411064A1 (ko)
CZ (1) CZ20024029A3 (ko)
DZ (1) DZ3383A1 (ko)
EA (1) EA004298B1 (ko)
GB (1) GB0014005D0 (ko)
HU (1) HUP0301799A3 (ko)
IL (1) IL153280A0 (ko)
MA (1) MA26912A1 (ko)
MX (1) MXPA02012173A (ko)
NO (1) NO20025882L (ko)
NZ (1) NZ522997A (ko)
OA (1) OA12283A (ko)
PL (1) PL363683A1 (ko)
SK (1) SK17152002A3 (ko)
WO (1) WO2001094343A1 (ko)
YU (1) YU93002A (ko)
ZA (1) ZA200300017B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
HUP0301799A3 (en) 2005-04-28
GB0014005D0 (en) 2000-08-02
BG107356A (bg) 2003-06-30
CZ20024029A3 (cs) 2003-04-16
YU93002A (sh) 2006-01-16
PL363683A1 (en) 2004-11-29
NZ522997A (en) 2004-05-28
DZ3383A1 (fr) 2001-12-13
EA004298B1 (ru) 2004-02-26
IL153280A0 (en) 2003-07-06
WO2001094343A1 (en) 2001-12-13
AU6255001A (en) 2001-12-17
JP2003535861A (ja) 2003-12-02
HUP0301799A2 (hu) 2003-12-29
OA12283A (en) 2003-11-10
CN1443185A (zh) 2003-09-17
BR0111508A (pt) 2003-03-25
AP2002002684A0 (en) 2002-12-31
EA200300004A1 (ru) 2003-04-24
MA26912A1 (fr) 2004-12-20
EP1292595A1 (en) 2003-03-19
KR20030007919A (ko) 2003-01-23
MXPA02012173A (es) 2003-04-25
CA2411064A1 (en) 2001-12-13
ZA200300017B (en) 2004-04-08
NO20025882L (no) 2003-01-29
AU2001262550B2 (en) 2004-04-22
US20040024027A1 (en) 2004-02-05
NO20025882D0 (no) 2002-12-06

Similar Documents

Publication Publication Date Title
SK14912001A3 (sk) Polymorfná forma soli 5-[4-[2-(N-metyl-N-2-pyridyl)amino)etoxy] benzyl]tiazolidín-2,4-diónu s kyselinou maleínovou, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
CA2314107A1 (en) 5-[4-[2- (n-methyl-n- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
EP1305312B1 (en) Tartrate salts of thiazolidinedione derivative
SK17152002A3 (sk) Hydrojodid 5-[4-[2-(N-metyl-N-(2-pyridyl)amíno)etoxy]- benzyl]tiazolidín-2,4-diónu ako liečivo
US20060004058A1 (en) Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl) amino) ethoxy!benzyl!thiazolidine -2, 4-dione
SK17142002A3 (sk) Soľ tiazolidindiónu na liečenie diabetes mellitus
EP1305311B1 (en) Tartrate salt of thiazolidinedione derivative
EP1305310B1 (en) Tartrate salts of thiazolidinedione derivative
CA2417828A1 (en) Tartrate salts of thiazolidinedione derivative
US20040038968A1 (en) Thiazolidinedione derivative and its use as antidiabetic
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
US20030162815A1 (en) Thiazolidinedione salt for treatment of diabetes mellitus
WO2003050112A1 (en) Toluenesulfonate hydrates of a thiazolidinedione derivative